Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial by Sherry, Nicole, Dr, Hagopian, William, MD, Ludvigsson, Johnny, Prof, Jain, Sunil M, MD, Wahlen, Jack, MD, Ferry, Robert J, Prof, Bode, Bruce, MD, Aronoff, Stephen, MD, Holland, Christopher, MS, Carlin, David, PhD, King, Karen L, MS, Wilder, Ronald L, MD, Pillemer, Stanley, MD, Bonvini, Ezio, MD, Johnson, Syd, PhD, Stein, Kathryn E, PhD, Koenig, Scott, MD, Herold, Kevan C, Prof, Daifotis, Anastasia G, MD

Get full text